PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 151.00
-5.00 (-3.21%)
Jul 16, 2026, 10:03 AM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 5.77 billion as of July 15, 2026. Its market cap has decreased by -34.75% in one year.
Market Cap
5.77B
Enterprise Value
3.31B
Revenue
711.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
151.00
Market Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 5.77B, a decrease of -67.68%. That is a compound annual growth rate of -42.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 5.77B | 0.13% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 7.22B |
| ADR Biomedical Holdings | 7.19B |
| MEDINET | 7.00B |
| Carna Biosciences | 6.98B |
| CellSource | 6.85B |
| Noile-Immune Biotech | 6.03B |
| Chiome Bioscience | 5.89B |
| Soiken Holdings | 5.60B |